Collaboration - June 4, 2015
AZ Might Consider CAR-T Firm
After AstraZeneca told Bloomberg it might be interested in a cancer therapy company, Juno Therapeutics’ stocks jumped by more than 15.3 percent this week, according to BioSpace.com. AstraZeneca’s CEO Pascal Soriot made the comments after he was asked whether his firm would be interested in a company like Juno, which develops ways the body can use its […]
Collaboration - April 27, 2015
Juno, AZ Testing Cancer Remedy
Juno Therapeutics and AstraZeneca are joining forces to test their respective cancer treatments, combining new therapies designed to use the body’s immune system to combat tumors. Under the deal, the pair plans to jointly fund a Phase I study combining one of Juno’s CAR-T therapies and pair it with a promising antibody developed by MedImmune, […]